{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:32:32Z","timestamp":1792852352981,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejca.2022.01.028","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T23:33:55Z","timestamp":1647041635000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea\/emesis registry in oncology (NERO)"],"prefix":"10.1016","volume":"166","author":[{"given":"Matti","family":"Aapro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Caprariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petio","family":"Chilingirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Chr\u00e1pav\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan-Ovidiu","family":"Curca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentia","family":"Gales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru C.","family":"Grigorescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Huszno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1ra","family":"Karl\u00ednov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Kellnerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Malej\u010d\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Marinca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Petru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"P\u0142u\u017canski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pokorn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Pribulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryna","family":"Rubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther G.","family":"Steger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Tesa\u0159ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubica","family":"Valekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolay","family":"Yordanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Walaszkowska-Czyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.01.028_bib1","series-title":"MASCC\/ESMO antiemetic guidelines","year":"2019"},{"key":"10.1016\/j.ejca.2022.01.028_bib2","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","article-title":"Antiemetics: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Hesketh","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.01.028_bib3","series-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines)","year":"2021"},{"key":"10.1016\/j.ejca.2022.01.028_bib4","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/annonc\/mds021","article-title":"The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)","volume":"23","author":"Aapro","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.01.028_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JOP.2012.000816","article-title":"Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study","volume":"10","author":"Gilmore","year":"2014","journal-title":"J Oncol Pract"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.028_bib6","first-page":"273","article-title":"Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy--a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines","volume":"23","author":"Yu","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib7","first-page":"557","article-title":"Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses","volume":"26","author":"Clark-Snow","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib8","first-page":"4099","article-title":"Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey","volume":"27","author":"Dielenseger","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib9","first-page":"1","article-title":"Practice patterns for prevention of chemotherapy-induced nausea and vomiting and antiemetic guideline adherence based on real-world prescribing data","volume":"25","author":"Aapro","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2022.01.028_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-013-2727-3","article-title":"Preference weights for chemotherapy side effects from the perspective of women with breast cancer","volume":"142","author":"Kuchuk","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2022.01.028_bib11","first-page":"219","article-title":"Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer","volume":"13","author":"Sun","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib12","first-page":"3141","article-title":"Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life","volume":"20","author":"Fern\u00e1ndez-Ortega","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib13","first-page":"151","article-title":"Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers","volume":"23","author":"Van Laar","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.01.028_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2022.01.028_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdw270","article-title":"MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.01.028_bib17","first-page":"35","article-title":"Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy","volume":"4","author":"Decker","year":"2006","journal-title":"J Support Oncol"},{"key":"10.1016\/j.ejca.2022.01.028_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.01.028_bib19","article-title":"Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: a quantitative market research-based survey","volume":"1","author":"Aapro","year":"2018","journal-title":"Cancer Rep"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2022.01.028_bib20","first-page":"S49","article-title":"Antiemetic research: future directions","volume":"19","author":"Olver","year":"2011","journal-title":"Support Care Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2022.01.028_bib21","first-page":"S63","article-title":"Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference","volume":"19","author":"Roila","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1200\/JCO.1998.16.2.771","article-title":"Assuring the optimal use of serotonin antagonist antiemetics: the process for development and\u00a0implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center","volume":"16","author":"Nolte","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.01.028_bib23","first-page":"3297","article-title":"Impact and management of chemotherapy\/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists\/oncology nurses and patients: a cross-sectional multinational survey","volume":"23","author":"Vidall","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.01.028_bib24","series-title":"Akynzeo (netupitant and palonosetron) capsules; Akynzeo (fosnetupitant and palonosetron) for injection [prescribing information]","year":"2020"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:35:52Z","timestamp":1760733352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":24,"alternative-id":["S0959804922000612"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.01.028","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea\/emesis registry in oncology (NERO)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}